» Articles » PMID: 19781837

Psychotherapy for Chronic Major Depression and Dysthymia: a Meta-analysis

Overview
Specialty Psychology
Date 2009 Sep 29
PMID 19781837
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Although several studies have examined the effects of psychotherapy on chronic depression and dysthymia, no meta-analysis has been conducted to integrate results of these studies. We conducted a meta-analysis of 16 randomized trials examining the effects of psychotherapy on chronic depression and dysthymia. We found that psychotherapy had a small but significant effect (d=0.23) on depression when compared to control groups. Psychotherapy was significantly less effective than pharmacotherapy in direct comparisons (d=-0.31), especially SSRIs, but that this finding was wholly attributable to dysthymic patients (the studies examining dysthymia patients were the same studies that examined SSRIs). Combined treatment was more effective than pharmacotherapy alone (d=0.23) but even more so with respect to psychotherapy alone (d=0.45), although again this difference may have reflected the greater proportion of dysthymic samples in the latter. No significant differences were found in drop-out rates between psychotherapy and the other conditions. We found indications that at least 18 treatment sessions are needed to realize optimal effects of psychotherapy. We conclude that psychotherapy is effective in the treatment of chronic depression and dysthymia but probably not as effective as pharmacotherapy (particularly the SSRIs).

Citing Articles

Schema therapy versus treatment as usual for outpatients with difficult-to-treat depression: study protocol for a parallel group randomized clinical trial (DEPRE-ST).

Arendt I, Gondan M, Juul S, Hastrup L, Hjorthoj C, Bach B Trials. 2024; 25(1):266.

PMID: 38627837 PMC: 11022394. DOI: 10.1186/s13063-024-08079-9.


The multi-level outcome study of psychoanalysis for chronically depressed patients with early trauma (MODE): rationale and design of an international multicenter randomized controlled trial.

Ambresin G, Leuzinger-Bohleber M, Fischmann T, Axmacher N, Hattingen E, Bansal R BMC Psychiatry. 2023; 23(1):844.

PMID: 37974088 PMC: 10652457. DOI: 10.1186/s12888-023-05287-6.


Identifying subgroups with differential response to CBASP versus Escitalopram during the first eight weeks of treatment in outpatients with persistent depressive disorder.

Serbanescu I, Schramm E, Walter H, Schnell K, Zobel I, Drost S Eur Arch Psychiatry Clin Neurosci. 2023; 274(3):723-737.

PMID: 37606728 PMC: 10995028. DOI: 10.1007/s00406-023-01672-0.


Group music therapy with songwriting for adult patients with long-term depression (SYNCHRONY study): a feasibility and acceptability study of the intervention and parallel randomised controlled trial design with wait-list control and nested process....

Carr C, Millard E, Dilgul M, Bent C, Wetherick D, French J Pilot Feasibility Stud. 2023; 9(1):75.

PMID: 37147699 PMC: 10161457. DOI: 10.1186/s40814-023-01285-3.


Individual- and Connectivity-Based Real-Time fMRI Neurofeedback to Modulate Emotion-Related Brain Responses in Patients with Depression: A Pilot Study.

Maywald M, Paolini M, Rauchmann B, Gerz C, Heppe J, Wolf A Brain Sci. 2022; 12(12).

PMID: 36552173 PMC: 9775232. DOI: 10.3390/brainsci12121714.